|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
NLM333040554 |
| 003 |
DE-627 |
| 005 |
20240828231904.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2021 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/VIW.20200082
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1515.xml
|
| 035 |
|
|
|a (DE-627)NLM333040554
|
| 035 |
|
|
|a (NLM)34766158
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Tan, Chianru
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Applications of digital PCR in COVID-19 pandemic
|
| 264 |
|
1 |
|c 2021
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Revised 28.08.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
| 520 |
|
|
|a © 2021 The Authors. VIEW published by Shanghai Fuji Technology Consulting Co., Ltd, authorized by Professional Community of Experimental Medicine, National Association of Health Industry and Enterprise Management (PCEM) and John Wiley & Sons Australia, Ltd.
|
| 520 |
|
|
|a The coronavirus disease 2019 (COVID-19) pandemic has led to a public health crisis and global panic. This infectious disease is caused by a novel coronavirus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Digital polymerase chain reaction (dPCR), which is an emerging nucleic acid amplification technology that allows absolute quantification of nucleic acids, plays an important role in the detection of SARS-CoV-2. In this review, we introduce the principle and advantages of dPCR, and review the applications of dPCR in the COVID-19 pandemic, including detection of low copy number viruses, measurement of the viral load, preparation of reference materials, monitoring of virus concentration in the environment, detection of viral mutations, and evaluation of anti-SARS-CoV-2 drugs. We also discuss the challenges of dPCR in clinical practice
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a COVID‐19
|
| 650 |
|
4 |
|a SARS‐CoV‐2
|
| 650 |
|
4 |
|a digital PCR
|
| 650 |
|
4 |
|a nucleic acid testing
|
| 700 |
1 |
|
|a Fan, Dongdong
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Nan
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Fang
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wang, Bo
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhu, Lingxiang
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Guo, Yong
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t View (Beijing, China)
|d 2020
|g 2(2021), 2 vom: 27. Apr., Seite 20200082
|w (DE-627)NLM333040546
|x 2688-268X
|7 nnns
|
| 773 |
1 |
8 |
|g volume:2
|g year:2021
|g number:2
|g day:27
|g month:04
|g pages:20200082
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/VIW.20200082
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_21
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_39
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_61
|
| 912 |
|
|
|a GBV_ILN_62
|
| 912 |
|
|
|a GBV_ILN_65
|
| 912 |
|
|
|a GBV_ILN_69
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_90
|
| 912 |
|
|
|a GBV_ILN_100
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_135
|
| 912 |
|
|
|a GBV_ILN_138
|
| 912 |
|
|
|a GBV_ILN_147
|
| 912 |
|
|
|a GBV_ILN_176
|
| 912 |
|
|
|a GBV_ILN_179
|
| 912 |
|
|
|a GBV_ILN_227
|
| 912 |
|
|
|a GBV_ILN_285
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_721
|
| 912 |
|
|
|a GBV_ILN_813
|
| 912 |
|
|
|a GBV_ILN_2001
|
| 912 |
|
|
|a GBV_ILN_2002
|
| 912 |
|
|
|a GBV_ILN_2003
|
| 912 |
|
|
|a GBV_ILN_2004
|
| 912 |
|
|
|a GBV_ILN_2005
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_2007
|
| 912 |
|
|
|a GBV_ILN_2008
|
| 912 |
|
|
|a GBV_ILN_2009
|
| 912 |
|
|
|a GBV_ILN_2010
|
| 912 |
|
|
|a GBV_ILN_2011
|
| 912 |
|
|
|a GBV_ILN_2012
|
| 912 |
|
|
|a GBV_ILN_2014
|
| 912 |
|
|
|a GBV_ILN_2015
|
| 912 |
|
|
|a GBV_ILN_2016
|
| 912 |
|
|
|a GBV_ILN_2018
|
| 912 |
|
|
|a GBV_ILN_2020
|
| 912 |
|
|
|a GBV_ILN_2031
|
| 912 |
|
|
|a GBV_ILN_2039
|
| 912 |
|
|
|a GBV_ILN_2285
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 2
|j 2021
|e 2
|b 27
|c 04
|h 20200082
|